ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2897

Exercise Therapy and/or Manual Therapy for Hip or Knee Osteoarthritis: 2-Year Follow-up of a Randomized Controlled Trial

J. Haxby Abbott1, Cathy Chapple2, Daniel Pinto3, Alexis Wright4 and Jean-Claude Theis5, 1Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand, 2School of Physiotherapy, University of Otago, Dunedin, New Zealand, 3Department of Physical Therapy & Human Movement Sciences, Northwestern University, Chicago, IL, 4Department of Physical Therapy, High Point University, High Point, NC, 5Centre for Musculoskeletal Outcomes Research, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: exercise, osteoarthritis and physical therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Osteoarthritis Risk Factors and Therapies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although both exercise therapy and manual therapy have evidence supporting their effectiveness in people with hip and knee osteoarthritis (OA), few clinical trials have reported their incremental effectiveness compared with usual medical care, or their long-term effects.

Methods: In this randomized controlled trial with 2-year follow-up, adults meeting the American College of Rheumatology criteria for hip or knee OA were randomly allocated to receive either a] exercise therapy; b] manual therapy; c] combined exercise therapy and manual therapy; or d] no trial intervention in addition to usual medical care. Groups a-c were provided 10 treatment sessions: 7 sessions within the first 9 weeks plus 3 booster sessions (2 at 4 months and 1 at 13 months). Assessors blinded to group allocation reassessed participants at 2 years. The primary outcome measures were the Western Ontario and McMaster (WOMAC) osteoarthritis index (24 questions, 0-10 scale, total range 0-240) and physical performance tests (timed up-and-go, 40m fast-paced walk, 30 second sit-to-stand).

Results: 186 (90.3%) of 206 participants recruited were retained at 2 years follow-up. At baseline, mean age was 66 years (range 37 to 92) and mean WOMAC was 100.8 (SD 53.8). Missing data were replaced using multiple imputation. Intention-to-treat analysis of covariance (ANCOVA) showed improvements in WOMAC at 2 years were superior for all three intervention groups compared with the usual care group (2-sided p<0.05). Participants receiving exercise therapy in addition to usual care showed gains of 31.7 WOMAC points (95% CI 10.0, 53.3); effect size 0.57 (Cohen’s d; 95% CI .17, .97). Participants receiving manual therapy in addition to usual care showed gains of 30.1 (8.9, 51.3); effect size 0.55 (.16, .94). Participants receiving combined exercise therapy and manual therapy in addition to usual care did not meet the a priori threshold for clinical significance (28 points), but were 26.2 (6.1, 46.3) WOMAC points better than usual care only, for a clinically significant effect size of 0.52 (.11, .91). The exercise therapy group showed greater mean changes on most physical performance tests than did the other groups.

Conclusion: Both exercise physiotherapy and manual physiotherapy provided incremental benefit over usual care alone at 2 years follow-up. Physical performance test outcomes significantly favoured the exercise therapy group.


Disclosure:

J. H. Abbott,
None;

C. Chapple,
None;

D. Pinto,
None;

A. Wright,
None;

J. C. Theis,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exercise-therapy-andor-manual-therapy-for-hip-or-knee-osteoarthritis-2-year-follow-up-of-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology